Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lonza Group Ag ADR (OP: LZAGY )

62.98 -1.34 (-2.08%)
Streaming Delayed Price Updated: 3:50 PM EST, Feb 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 23,942
Open 63.50
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 64.32
Today's Range 62.92 - 63.57
52wk Range 41.22 - 68.29
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Swiss Contract Service Provider Lonza Exits Capsules Business To Focus On Drug Development
Lonza unveils its "One Lonza" strategy, highlighting a new structure to streamline operations, strengthen CDMO leadership, and project 20% CER sales growth in 2025. 
Via Benzinga
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
Lonza expands biologics manufacturing capacity with acquisition of Genentech facility in Vacaville, CA. $1.2 billion deal includes employee retention and facility upgrades. Transaction expected to... 
Via Benzinga

Performance

YTD
+7.33%
+7.33%
1 Month
-3.27%
-3.27%
3 Month
+7.68%
+7.68%
6 Month
-4.33%
-4.33%
1 Year
+19.24%
+19.24%

More News

Read More
Galapagos Bets €225M On CellPoint Marking Its Entry Into CAR-T Field
Via Benzinga
Should You Have Lonza Stock on Your Watchlist?
Via The Motley Fool
Exposures COVID-19
Moderna, Lonza Team Up To Produce New Drug Substance for COVID-19 Vaccine Doses
Via Benzinga
Exposures COVID-19
Moderna Tries To Boost COVID-19 Vaccine Supply Chain To Produce 3B Doses Annually
Via Benzinga
Exposures COVID-19
aTyr Pharma Recruits Lonza As Manufacturing Partner For Cancer Therapy ATYR2810
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.